| | | | |
CUSIP No. 77634L 105 | | Schedule 13D | | Page 11 of 13 |
This Amendment No. 9 (the “Amendment”) amends and supplements the Schedule 13D filed by the Reporting Persons on July 1, 2022, as amended on October 3, 2023, February 7, 2024, February 26, 2024, April 29, 2024, May 7, 2024, June 14, 2024, July 1, 2024 and July 2, 2024 (collectively, the “Original Schedule 13D” and, as amended and supplemented by this Amendment, this “Statement”), with respect to the Common Stock. Capitalized terms used in this Amendment and not otherwise defined shall have the same meanings ascribed to them in the Original Schedule 13D.
Item 4. Purpose of Transaction.
Item 4 of the Original Schedule 13D is amended and supplemented by adding the following:
As previously disclosed in this Statement, on July 2, 2024, New Mountain Capital L.L.C., on behalf of certain managed funds, delivered to the Special Committee of the Board of Directors of the Issuer a non-binding proposal to acquire all of the outstanding shares of Common Stock of the Issuer (other than shares owned by CoyCo 1, L.P. and CoyCo 2, L.P. or their respective affiliates).
On August 1, 2024, the Issuer announced that it entered into an Agreement and Plan of Merger with Raven Acquisition Holdings, LLC, a Delaware limited liability company (“Parent”), and Project Raven Merger Sub, Inc., a Delaware corporation and wholly owned subsidiary of Parent (“Merger Sub”, and together with Parent, the “Buyer Parties”) pursuant to which, among other things, the Buyer Parties have agreed to acquire all of the outstanding shares of Common Stock of the Issuer that TCP-ASC ACHI Series LLLP does not currently own for a purchase price of $14.30 per share in cash. As a result, New Mountain Capital L.L.C. is no longer actively pursuing an acquisition of the Issuer.
At this time, the Reporting Persons reserve the right to change their intentions with respect to the Issuer and its securities, including with respect to actions which could involve one or more of the types of transactions or have one or more of the results described in Items 4(a) through (j) of Schedule 13D.
Item 5. Interest in Securities of the Issuer.
Item 5 of the Original Schedule 13D is amended and restated in its entirety as follows:
The information contained in rows 7, 8, 9, 10, 11 and 13 on each of the cover pages of this Statement and the information set forth or incorporated in Items 2, 3, 4 and 6 is incorporated by reference in its entirety into this Item 5.
(a) and (b) The percentages in this Item 5 and in other provisions of this Statement relating to beneficial ownership of Common Stock are based on based on 421,255,230 shares of Common Stock outstanding as of May 8, 2024, as reported by the Issuer in the Form 10-Q.
(c) None of the Reporting Persons has effected any transaction in the shares of Common Stock during the past 60 days.
(d) No other person is known to the Reporting Persons to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the shares of Common Stock covered by this Statement.
(e) Not applicable.
Item 7. Materials to be Filed as Exhibits.
None.